Table 1.
Participants’ clinical characteristics.
| Min–Max | Mean (SD) | Median (IR) | |
|---|---|---|---|
| Length of ED in months (n = 41) | 12–317 | 119.27 (93.15) | 77.00 (174) |
| Delay in visiting first specialized ED treatment team in months (n = 40) | 0–306 | 86.40 (88.23) | 51.50 (114.00) |
| Number of previous specialized treatments (n = 35) | 0–9 | 2.00 (2.02) | 1.00 (2.00) |
| Number of hospitalizations for ED (n = 38) | 0–5 | 0.68 (1.17) | 0.00 (1.00) |
| Number of medical complications (n = 41) | 0–6 | 1.37 (1.67) | 1.00 (2.00) |
| EDE-Q Global score (n = 41) | 0–6 | 3.66 (1.48) | 4.01 (2.00) |
| CIA Global score (n = 41) | 0–46 | 30.49 (12.29) | 34.00 (18.00) |
Min, minimum; max, maximum; SD, standard deviation; IR, interquartile range; n, number of participants with valid data.